dyspepsia
DYSPEPSIA

Dyspepsia is having any one of the following: disturbing postprandial fullness, early satiation, epigastric pain and/or burning felt predominantly in the upper abdomen.

It is considered a symptom complex rather than a specific diagnosis.

Acid suppression is the recommended initial therapy.

  1. Delaney BC, Moayyedi P, Forman D. Initial management strategies for dyspepsia [abstract]. Cochrane Database Syst Rev. 2003(2):CD001961. PMID: 12804417
  2. Veldhuyzen van Zanten SJ, Flook N, Chiba N, et al. An evidence-based approach to the management of uninvestigated dyspepsia in the era of Helicobacter pylori. CMAJ. 2000 Jun;162(12 Suppl):S3-S23. PMID: 10870511
  3. Moayyedi P, Soo S, Deeks L, et al. Pharmacological interventions for non-ulcer dyspepsia [abstract]. Cochrane Database Syst Rev. 2003(1):CD001960. PMID: 12535421
  4. Schroeder BM. Evaluation of epigastric discomfort and management of dyspepsia and GERD. Am Fam Physician. 2003 Sep;68(6):1215-1220. PMID: 14524407
  5. Talley NJ. Dyspepsia: management guidelines for the millennium. Gut. 2002 May;50(Suppl 4):iv72-78. PMID: 11953354
  6. Simren M, Tack J. Functional dyspepsia: evaluation and treatment. Gastroenterol Clin North Am. 2003 Jun;32(2):577-599. PMID: 12858607
  7. Talley NJ, Vakil N; Practice Parameters Committee of the American College of Gastroenterology. Guidelines for the management of dyspepsia. Am J Gastroenterol. 2005 Oct;100(10):2324-2337. PMID: 16181387
  8. Talley NJ. Update on the role of drug therapy in non-ulcer dyspepsia. Rev Gastroenterol Disord. 2003;3(1):25-30. PMID: 12684590
  9. Talley NJ, Silverstein MD, Agréus L, Nyrén O, Sonnenberg A, Holtmann G. AGA technical review: evaluation of dyspepsia. Gastroenterology. 1998 Mar;114(3):582-595. PMID: 9496950
  10. Soll AH, Graham DY. Approach to the patient with dyspepsia and peptic ulcer disease. In: Yamada T, Alpers DH, Kalloo AN, eds. Principles of clinical gastroenterology. 1st ed. West Sussex; 2008
  11. MedWormhttp://www.medworm.com/rss/index.php/Gastroenterology/17/http://www.medworm.com/rss/medicalfeeds/specialities/Gastroenterology.xml
  12. MedWormhttp://www.medworm.com/rss/index.php/Pediatrics/33/http://www.medworm.com/rss/medicalfeeds/specialities/Pediatrics.xml
  13. Scottish Intercollegiate Guidelines Network. Dyspepsia. A national clinical guideline. SIGN. http://www.guideline.gov/content.aspx?id=3723. Mar 2003
  14. National Institute for Health and Care Excellence. Dyspepsia: Managing dyspepsia in adults in primary care. NICE. http://www.nice.org.uk. Aug 2004
  15. North of England Dyspepsia Guideline Development Group. Dyspepsia: managing dyspepsia in adults in primary care: evidence-based clinical practice guideline. http://www.nice.org.uk/nicemedia/pdf/cg017fullguideline.pdf. Aug 2004
  16. New Zealand Guidelines Group. Management of dyspepsia and heartburn: evidence-based practice guideline. http://www.health.govt.nz/publication/management-dyspepsia-and-heartburn. Jun 2004
  17. Longstreth GF, Lacy BE. Approach to the adult with dyspepsia. UpToDate. http://www.uptodate.com/contents/approach-to-the-adult-with-dyspepsia#H63380126. 28 Aug 2013. Accessed 20 Jan 2014
  18. Loyd RA, McClellan DA. Update on the evaluation and management of functional dyspepsia. Am Fam Physician. 2011;83(5):547-552. http://www.aafp.org/afp/2011/0301/p547.pdf. Accessed 20 Jan 2014. PMID: 21391521
  19. Miwa H, Kusano M, Arisawa T, et al; Japanese Society of Gastroenterology. Evidence-based clinical practice guidelines for functional dyspepsia. J Gastroenterol. 2015 Feb;50(2):125-139. doi: 10.1007/s00535-014-1022-3. PMID: 25586651
  20. Tack J, Camilleri M, Chang L, et al. Systematic review: cardiovascular safety profile of 5-HT(4) agonists developed for gastrointestinal disorders. Aliment Pharmacol Ther. 2012 Apr;35(7):745-767. doi: 10.1111/j.1365-2036.2012.05011.x. PMID: 22356640
  21. Wiśniowska B, Tylutki Z, Wyszogrodzka G, et al. Drug-drug interactions and QT prolongation as a commonly assessed cardiac effect - comprehensive overview of clinical trials. BMC Pharmacol Toxicol. 2016 Mar 10;17:12. doi: 10.1186/s40360-016-0053-1. PMID: 26960809
  22. Stanghellini V, Chan FK, Hasler WL, et al. Gastroduodenal disorders. Gastroenterology. 2016 May;150(6):1380-1392. doi: 10.1053/j.gastro.2016.02.011. PMID: 27147122
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Gastroenterology - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
01 May 2014

New drug applications approved by US FDA as of 15-30 May which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

12 Apr 2017
Patients with fibromyalgia syndrome (FMS) are at an increased risk of peptic ulcer disease (PUD), a new study shows.
08 May 2017
Transabdominal bowel wall ultrasonography shows utility in monitoring disease activity in patients with active Crohn’s disease (CD), according to a study. The imaging technique is ideal for evaluating early transmural changes in disease activity, in response to medical treatment.
01 Jun 2015
A mixture of the flavonoids diosmin, troxerutin, and hesperidin is safe and effective for the symptomatic management of patients with acute haemorrhoidal disease, a prospective, randomised, triple-blind, controlled trial revealed.